David Tuller
May 23, 2016 at 17:45
Thanks, Leonid, for the excellent round-up of data shenanigans with the FINE trial. It is important to note that although FINE did not engage in the egregious data manipulation that PACE did, the authors did in fact revise their primary outcomes to make their results appear better. Let’s be clear: At the protocol-designated primary outcome of 70 weeks, FINE had completely NULL results. However, in publishing the report, the authors engaged in serious “outcome-switching.” The authors falsely claimed in the published paper, that the 20-week assessment point AND the 70-week point were in fact co-primary outcome points. Since they had modest but transient improvements in fatigue at 20 weeks–these had disappeared by 70 weeks–the paper cited this as a co-primary outcome in order not to report completely NULL results. In fact, the FINE protocol, published in the journal BMC Medicine in 2006, declared flatly “short-term assessments of outcome [i.e. at 20 weeks] in a chronic health condition such as CFS/ME can be misleading.” That’s why only the 70-week assessment, not the 20-week assessment, was designated as THE “primary outcome point.”
In an accompanying editorial, BMJ did not call out FINE on this outcome-switching and in fact repeated it by citing this purportedly “positive” result, while only later mentioning the completely NULL results at 70 weeks. The authors subsequently published, in a letter to the editor, a non-peer-reviewed, post-hoc re-scoring of the fatigue scale that demonstrated modest improvements at 70 weeks. Since then, they have claimed this as their main finding, routinely failing to mention that this was a post-hoc re-scoring that was presumably not peer-reviewed. This isn’t quite as bad as what the PACE authors did–but it’s still plenty dishonest and anti-scientific. Alison Wearden, like the PACE authors, has never explained these discrepancies.
Not surprisingly, the PACE authors have never mentioned the NULL findings in any of their published work, despite having for years referred to FINE as its “sister trial.” I covered the whole pathetic story of how FINE was “disappeared” last fall, on Virology Blog:
http://www.virology.ws/2015/11/09/trial-by-error-continued-why-has-the-pace-studys-sister-trial-been-disappeared-and-forgotten/
Keep up the good work, Leonid!!